Artículo

La versión final de este artículo es de uso interno de la institución.
Consulte el artículo en la página del editor
Consulte la política de Acceso Abierto del editor

Abstract:

Knowing the importance for research and pharmacological uses of proper ligand classification into agonists, inverse agonists, and antagonists, the aim of this work was to study the behavior of tiotidine, a controversial histamine H2 receptor ligand. We found that tiotidine, described previously as an H2 antagonist, actually behaves as an inverse agonist in U-937 cells, diminishing basal cAMP levels. [3H]Tiotidine showed two binding sites, one with high affinity and low capacity and the other with low affinity and high capacity. The former site disappeared in the presence of guanosine 5′-O-(3-thio)triphosphate, indicating that it belongs to a subset of receptors coupled to G-protein, showing the classic binding profile for an agonist. Considering the occupancy models developed up to now, the only one that explains tiotidine dual behavior is the cubic ternary complex (CTC) model. This model allows G-protein to interact with the receptor even in the inactive state. We showed by theoretical simulations based on the CTC model of dose-response and binding experiments that tiotidine biases the system to a G-protein-coupled form of the receptor that is unable to evoke a response. This theoretical approach was supported by experimental results in which an unrelated G-protein-coupled receptor that also signals through Gαs-protein (β2-adrenoreceptor) was impeded by tiotidine. This interference clearly implies that tiotidine biases the system to Gαs-coupled form of the H2 receptor and turns Gαs-protein less available to interact with β2-adrenoreceptor. These findings not only show that tiotidine is an H2 inverse agonist in U-937 cells but also provide experimental support for the CTC model.

Registro:

Documento: Artículo
Título:Tiotidine, a histamine H2 receptor inverse agonist that binds with high affinity to an inactive G-protein-coupled form of the receptor. Experimental support for the cubic ternary complex model
Autor:Monczor, F.; Fernández, N.; Legnazzi, B.L.; Riveiro, M.E.; Baldi, A.; Shayo, C.; Davio, C.
Filiación:Laboratorio de Radioisótopos, Facultad de Farmacia y Bioquimica, Universidad de Buenos Aires, Buenos Aires, Argentina
Depto. Fisiologia, Biol. Molec. Cel., Fac. de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina
Consejo Nac. Invest. Cie. Tecnicas, Buenos Aires, Argentina
Inst. de Biologia y Med. Exprimental, Buenos Aires, Argentina
Laboratorio de Radioisótopos, Facultat de Farmacia y Bioquimica, Universidad de Buenos Aires, Junin 956 PB, 1113, Capital Federal, Argentina
Palabras clave:beta 2 adrenergic receptor; G protein coupled receptor; guanosine 5' o (3 thiotriphosphate); histamine H2 receptor; histamine H2 receptor agonist; histamine H2 receptor antagonist; tiotidine; animal cell; article; controlled study; dose response; drug activity; drug receptor binding; drug use; human; human cell; nonhuman; priority journal; signal transduction; Animals; Cimetidine; COS Cells; Dose-Response Relationship, Drug; Histamine Agonists; Histamine H2 Antagonists; Humans; Models, Biological; Receptors, Histamine H2; Transfection; Tritium; Tumor Cells, Cultured; U937 Cells
Año:2003
Volumen:64
Número:2
Página de inicio:512
Página de fin:520
DOI: http://dx.doi.org/10.1124/mol.64.2.512
Título revista:Molecular Pharmacology
Título revista abreviado:Mol. Pharmacol.
ISSN:0026895X
CODEN:MOPMA
CAS:guanosine 5' o (3 thiotriphosphate), 37589-80-3; tiotidine, 69014-14-8; Cimetidine, 51481-61-9; Histamine Agonists; Histamine H2 Antagonists; Receptors, Histamine H2; tiotidine, 69014-14-8; Tritium, 10028-17-8
Registro:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_0026895X_v64_n2_p512_Monczor

Referencias:

  • Alewijnse, A.E., Timmerman, H., Jacobs, E.H., Smit, M.J., Roovers, E., Cotecchia, S., Leurs, R., The effect of mutations in the DRY motif on the constitutive activity and structural instability of the histamine H2 receptor (2000) Mol Pharmacol, 57, pp. 890-898
  • Batzri, S., Harmon, J.W., Is [3H]-tiotidine a specific ligand for the H2-receptor? (1986) Pharmacology, 32, pp. 241-247
  • Bouaboula, M., Parrachon, S., Milligan, L., Canat, X., Rinaldi-Carmona, M., Portier, M., Barth, F., Lupker, J., A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1 (1997) J Biol Chem, 272, pp. 22330-22339
  • Brown, G.P., Pasternak, G.W., 3H-Naloxone benzoylhydrazone binding in MOR-1-transfected Chinese hamster ovary cells: Evidence for G-protein-dependent antagonist binding (1998) J Pharmacol Exp Ther, 286, pp. 376-381
  • Chidiac, P., Hebert, T.E., Valiquette, M., Dennis, M., Bouvier, M., Inverse agonist activity of β-adrenergic agonists (1994) Mol Pharmacol, 45, pp. 490-499
  • Davio, C., Baldi, A., Shayo, C., Brodsky, A., Cricco, G., Bergoc, R., Rivera, E., H1 and H2 histamine receptors in histiocytic lymphoma cell line U937 (1995) Inflamm Res, 44, pp. S72-S73
  • Davio, C., Cricco, G., Bergoc, R., Rivera, E., H1 and H2 histamine receptors in N-nitroso-N-methylurea (NMU)-induced carcinomas with atypical coupling to signal transducers (1995) Biochem Pharmacol, 50, pp. 91-96
  • De Léan, A., Stadel, J.M., Lefkowitz, R.J., A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor (1980) J Biol Chem, 255, pp. 7108-7117
  • Del Valle, J., Gantz, I., Novel insights into histamine H2 receptor biology (1997) Am J Physiol, 273, pp. G987-G996
  • Fernández, N., Monczor, F., Lemos, B., Notcovich, C., Baldi, A., Davio, C., Shayo, C., Reduction of G protein-coupled receptor kinase 2 expression in U-937 cells attenuates H2 histamine receptor desensitization and induces cell maturation (2002) Mol Pharmacol, 62, pp. 1506-1514
  • Hall, A., Strange, P.G., Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptors (1997) Br J Pharmacol, 121, pp. 731-736
  • Hilser, V.J., Dowdy, D., Oas, T.G., Freire, E., The structural distribution of cooperative interactions in proteins: Analysis of the native state ensemble (1998) Proc Natl Acad Sci USA, 18, pp. 9903-9908
  • Kenakin, T., Morgan, P., Lutz, M., On the importance of the "antagonist assumption" to how receptors express themselves (1995) Biochem Pharmacol, 50, pp. 17-26
  • Kjelsberg, M.A., Cotecchia, S., Ostrowski, J., Caron, M.G., Lefkowitz, R.J., Constitutive activation of the α1β-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation (1992) J Biol Chem, 267, pp. 1430-1433
  • Lemos, B., Shayo, C., Monczor, F., Martin, M.E., Fernandez, N., Brodsky, A., Baldi, A., Davio, C., Rapid desensitization and slow recovery of cyclic AMP response mediated by histamine H2 receptors in U-937 cell line (2000) Biochem Pharmacol, 60, pp. 159-166
  • Leurs, R., Hoffmann, M., Alewijnse, A.E., Smit, M.J., Timmerman, H., Methods to determine the constitutive activity of histamine H2 receptors (2002) Methods Enzymol, 343, pp. 405-416
  • Milligan, G., The stoichiometry of expression of protein components of the stimulatory adenylyl cyclase cascade and the regulation of information transfer (1996) Cell Signal, 8, pp. 87-96
  • Monczor, F., Legnazzi, B.L., Rivera, E., Davio, C., Tiotidine, a classical H2-antagonist, presents characteristics of an inverse agonist in U937 cell line (1998) Inflamm Res, 47, pp. S42-43
  • Munson, P.J., Rodbard, D., Ligand: A versatile computerized approach for characterization of ligand-binding systems (1980) Anal Biochem, 107, pp. 220-239
  • Parma, J., Duprez, L., Van Sande, J., Cochaux, P., Gervy, C., Mockel, J., Dumont, J., Vassart, G., Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas (1993) Nature (Lond), 865, pp. 649-651
  • Rising, T.J., Norris, D.B., Histamine H2 receptor radioligand studies (1985) Frontiers in Histamine Research, pp. 61-67. , (Ganellin CR and Schwartz JC eds), Pergamon, Oxford
  • Rossier, O., Abuin, L., Fanelli, F., Leonardi, A., Cotecchia, S., Inverse agonism and neutral antagonism at α1a and α1b adrenergic receptor subtypes (1999) Mol Pharmacol, 56, pp. 858-866
  • Samama, P., Cotecchia, S., Costa, T., Lefkowitz, R.J., A mutation-induced activated state of the β2-adrenergic receptor. Extending the ternary complex model (1993) J Biol Chem, 268, pp. 4625-4636
  • Shayo, C., Fernandez, N., Lemos Legnazzi, B., Monczor, F., Mladovan, A., Baldi, A., Davio, C., Histamine H2 receptor desensitization. Involvement of a select array of G protein-coupled receptor kinases (2001) Mol Pharmacol, 60, pp. 1049-1056
  • Shenker, A., Laue, L., Kosugi, S., Merendino J.J., Jr., Minegishi, T., Cutler G.B., Jr., A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty (1993) Nature (Lond), 365, pp. 652-654
  • Smit, M.J., Leurs, R., Alewijnse, A.E., Blauw, J., Van Nieuw Amerongen, G.P., Van De Vrede, Y., Roovers, E., Timmerman, H., Inverse agonism of histamine H2 antagonists accounts for up-regulation of spontaneously active histamine H2 receptors (1996) Proc Natl Acad Sci USA, 93, pp. 6802-6807
  • Van der Goot, H., Bast, A., Timmerman, H., Structural requirements for histamine H2 agonists and H2 antagonists (1991) Handbook of Experimental Pharmacology, 97, pp. 573-748. , (Arrang J-M, Uvnäs Bed) Springer-Verlag, Berlin
  • Van der Goot, H., Timmerman, H., Selective ligands as tools to study histamine receptors (2000) Eur J Med Chem, 35, pp. 5-20
  • Weiss, J.M., Morgan, P.H., Lutz, M.W., Kenakin, T.P., The cubic ternary complex receptor-occupancy model. I. Model description (1996) J Theor Biol, 178, pp. 151-167
  • Weiss, J.M., Morgan, P.H., Lutz, M.W., Kenakin, T.P., The cubic ternary complex receptor-occupancy model. II. Understanding apparent affinity (1996) J Theor Biol, 178, pp. 169-182
  • Weiss, J.M., Morgan, P.H., Lutz, M.W., Kenakin, T.P., The cubic ternary complex receptor hyphen occupancy model. III. Resurrecting efficacy (1996) J Theor Biol, 181, pp. 381-397
  • Westphal, R.S., Sanders-Bush, E., Reciprocal binding properties of 5HT2c receptor agonists and antagonists (1994) Mol Pharmacol, 46, pp. 937-942

Citas:

---------- APA ----------
Monczor, F., Fernández, N., Legnazzi, B.L., Riveiro, M.E., Baldi, A., Shayo, C. & Davio, C. (2003) . Tiotidine, a histamine H2 receptor inverse agonist that binds with high affinity to an inactive G-protein-coupled form of the receptor. Experimental support for the cubic ternary complex model. Molecular Pharmacology, 64(2), 512-520.
http://dx.doi.org/10.1124/mol.64.2.512
---------- CHICAGO ----------
Monczor, F., Fernández, N., Legnazzi, B.L., Riveiro, M.E., Baldi, A., Shayo, C., et al. "Tiotidine, a histamine H2 receptor inverse agonist that binds with high affinity to an inactive G-protein-coupled form of the receptor. Experimental support for the cubic ternary complex model" . Molecular Pharmacology 64, no. 2 (2003) : 512-520.
http://dx.doi.org/10.1124/mol.64.2.512
---------- MLA ----------
Monczor, F., Fernández, N., Legnazzi, B.L., Riveiro, M.E., Baldi, A., Shayo, C., et al. "Tiotidine, a histamine H2 receptor inverse agonist that binds with high affinity to an inactive G-protein-coupled form of the receptor. Experimental support for the cubic ternary complex model" . Molecular Pharmacology, vol. 64, no. 2, 2003, pp. 512-520.
http://dx.doi.org/10.1124/mol.64.2.512
---------- VANCOUVER ----------
Monczor, F., Fernández, N., Legnazzi, B.L., Riveiro, M.E., Baldi, A., Shayo, C., et al. Tiotidine, a histamine H2 receptor inverse agonist that binds with high affinity to an inactive G-protein-coupled form of the receptor. Experimental support for the cubic ternary complex model. Mol. Pharmacol. 2003;64(2):512-520.
http://dx.doi.org/10.1124/mol.64.2.512